|
PAICS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.37939999609461E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.90869583763742E-11 |
| Normal-vs-Stage2 |
7.450000E-02 |
| Normal-vs-Stage3 |
5.162800E-01 |
| Normal-vs-Stage4 |
9.808200E-02 |
| Stage1-vs-Stage2 |
1.553220E-01 |
| Stage1-vs-Stage3 |
5.316200E-03 |
| Stage1-vs-Stage4 |
9.239800E-03 |
| Stage2-vs-Stage3 |
3.354200E-01 |
| Stage2-vs-Stage4 |
2.943900E-02 |
| Stage3-vs-Stage4 |
7.177700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.29849999980425E-07 |
| Normal-vs-AfricanAmerican |
4.20769999998072E-06 |
| Normal-vs-Asian |
3.896200E-02 |
| Caucasian-vs-AfricanAmerican |
5.809800E-01 |
| Caucasian-vs-Asian |
7.370800E-01 |
| AfricanAmerican-vs-Asian |
5.575600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14820050636888E-10 |
| Normal-vs-Female |
2.993200E-01 |
| Male-vs-Female |
1.582480E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.346300E-02 |
| Normal-vs-Extreme_Weight |
8.01590016585862E-10 |
| Normal-vs-Obese |
9.423400E-03 |
| Normal-vs-Extreme_Obese |
3.1830000000177E-06 |
| Normal_Weight-vs-Extreme_Weight |
4.006200E-02 |
| Normal_Weight-vs-Obese |
8.307600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.384400E-02 |
| Extreme_Weight-vs-Obese |
2.845700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.870200E-01 |
| Obese-vs-Extreme_Obese |
4.370500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.500000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.43179999999521E-05 |
| Normal-vs-Age(61-80Yrs) |
1.29690036487773E-10 |
| Normal-vs-Age(81-100Yrs) |
6.811200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.827900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.032340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.617600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.885800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.372200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.071200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67010849594362E-12 |
| Normal-VS-Type2 PRCC |
9.104000E-03 |
| Normal-VS-KIRP CIMP |
5.758300E-03 |
| Normal-VS-Unclassified PRCC |
6.260400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.155000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
3.557700E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.31030000000088E-05 |
| Type2 PRCC-VS-KIRP CIMP |
1.72130000031245E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
8.961200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.316740E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.221700E-04 |
| Normal-vs-N1 |
2.204800E-01 |
| Normal-vs-N2 |
1.678380E-01 |
| N0-vs-N1 |
4.777700E-03 |
| N0-vs-N2 |
1.402430E-04 |
| N1-vs-N2 |
1.376750E-01 |
|
|
